Company Filing History:
Years Active: 1993-1996
Title: The Innovations of Gerald R Girard
Introduction
Gerald R Girard is a notable inventor based in Bensalem, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in the area of hypertension and related conditions. With a total of four patents to his name, Girard's work has had a meaningful impact on medical treatments.
Latest Patents
One of Girard's latest patents involves a method of antagonizing angiotensin II receptors in mammals. This patent focuses on angiotensin II receptor antagonists that are useful in regulating hypertension and treating conditions such as congestive heart failure, renal failure, and glaucoma. The pharmaceutical compositions he developed include these antagonists and methods for using these compounds to achieve angiotensin II receptor antagonism in mammals. Additionally, he has worked on N-(heteroaryl) imidazolyl-alkenoic acids that target angiotensin II receptors.
Career Highlights
Girard is associated with SmithKline Beecham Corporation, where he has been able to apply his innovative ideas in a collaborative environment. His work has contributed to advancements in pharmaceutical science, particularly in the development of treatments for serious health conditions.
Collaborations
Throughout his career, Girard has collaborated with notable colleagues such as David T Hill and Joseph Weinstock. These collaborations have likely enhanced the quality and scope of his research and inventions.
Conclusion
Gerald R Girard's contributions to the field of pharmaceuticals demonstrate his commitment to innovation and improving health outcomes. His patents reflect a deep understanding of complex medical issues and a dedication to finding effective solutions.